Charlie Ergen -- CEO of Dish Network -- is taking a huge gamble with his recent unsolicited bid for Sprint, as the deal only sounds promising in theory. More
Should I Buy Rite Aid? 3 Pros, 3 Cons
Rite Aid's turnaround continues to gain traction, but does that make it a solid investment? Decide by looking at RAD's pros and cons. More
5 Biotechnology Stocks to Buy Now
This week, five Biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy"). More
VIDEO: 6 Stocks in 60 Seconds
Check out this quick video recap of six stocks that made headlines -- good and bad -- this week. More
Who’s Really Winning the App Store Battle?
The number of apps in Apple's App Store and Android's GooglePlay are neck-and-neck. So why is Apple dominating in sales? More
Patience Is a Virtue, Especially in Investing
Investors sometimes make the mistake of panic-selling out of good positions at the drop of a hat. Stay patient, and remember there are only a few good reasons to bail. More
3 Semiconductor Stocks to Buy Now
Three Semiconductor stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More
